DISCOUNT OPTIONSSCHEIN - AMGEN | Market Closed - Börse Stuttgart 19:48:12 10/05/2024 BST | ||
| 0.9 EUR | -2.17% |
|
| Current month | +11.11% | ||
| 1 month | -7.22% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/05/24 | 0.9 | -2.17% | 0 |
| 09/05/24 | 0.92 | +3.37% | 0 |
| 08/05/24 | 0.89 | +1.14% | 0 |
| 07/05/24 | 0.88 | +4.76% | 0 |
| 06/05/24 | 0.84 | -23.64% | 0 |
Delayed Quote Börse Stuttgart
Last update May 10, 2024 at 07:48 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | Morgan Stanley |
| WKN | ME6QK0 |
| ISIN | DE000ME6QK04 |
| Date issued | 10/01/2024 |
| Strike | 370 $ |
| Maturity | 21/06/2024 (42 Days) |
| Parity | 1 : 1 |
| Emission price | 1.67 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.73 € |
|---|---|
| Lowest since issue | 0.57 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
310.2
USD
Average target price
313.8
USD
Spread / Average Target
+1.18%
- Stock Market
- Certificates
- Certificat
